ETON PHARMACEUTICALS INC (ETON:NASDAQ)
$50.27 0.27 (0.54%)
Analysed ETON PHARMACEUTICALS INC (ETON:NASDAQ) News Sources
This Analyst Believes Eton Pharma’s Raised Guidance Is ‘Conservative’ – ETON Stock Heads For Best Ever Day
14-08-2026
stocktwits.com
Why Eton Pharmaceuticals Is Top of the Class Today
14-08-2026
fool.com
Is Eton Pharmaceuticals (ETON) Fully Priced On Strong Q2 Results And Raised Guidance?
15-08-2026
yahoo.com
Eton Pharmaceuticals (ETON) Q2 2026 Earnings Call Transcript
20-08-2026
fool.com
Three Biotech Stocks Stick Out With Their Stellar Charts
21-08-2026
yahoo.com
Eton Pharmaceuticals to Participate at 2026 Wells Fargo Healthcare Conference
27-08-2026
yahoo.com
Jim Cramer Explains Mad Money Caller How to Handle Eton Pharmaceuticals (ETON)
28-08-2026
yahoo.com
Eton Pharmaceuticals Announces U.S. Commercial Availability of IMPAVIDO® (miltefosine) Capsules
28-09-2026
yahoo.com
Eton Pharmaceuticals and Aquestive Therapeutics Announce Exclusive U.S. Licensing Agreement for LIBERVANT® (diazepam) Buccal Film
14-10-2026
yahoo.com
Eton Pharmaceuticals (ETON) Stock Still Looks Rich Despite Its New Seizure Drug License
22-10-2026
yahoo.com
What is the current price of ETON PHARMACEUTICALS INC (ETON:NASDAQ)?
The current price of ETON PHARMACEUTICALS INC (ETON:NASDAQ) is $50.27.
ETON PHARMACEUTICALS INC (ETON:NASDAQ) absolute price change since previous trading day?
The absolute price change of ETON PHARMACEUTICALS INC (ETON:NASDAQ) since the previous trading day is $0.27.
ETON PHARMACEUTICALS INC (ETON:NASDAQ) percentage price change since previous trading day?
The percentage price change of ETON PHARMACEUTICALS INC (ETON:NASDAQ) since the previous trading day is 0.54%.
What is the most recent average sentiment score for ETON PHARMACEUTICALS INC (ETON:NASDAQ)?
The most recent average sentiment score for ETON PHARMACEUTICALS INC (ETON:NASDAQ) is 88 out of 100.
What is the most recent average sentiment for ETON PHARMACEUTICALS INC (ETON:NASDAQ)?
The most recent sentiment for ETON PHARMACEUTICALS INC (ETON:NASDAQ) is .
SEC-8K** Filing Available For ETON PHARMACEUTICALS INC (ETON:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.